Updated 20:04 GMT, 28 Oct 2026 SPX 7,744.01 +0.28% NDX 29,813.16 +0.55% VIX 16.87 -3.71% GOLD 4,077.30 +0.07% CL 102.52 +2.62% BTC 81,597.92 +0.98%
NAS100 29,813 +0.55% S&P 7,744 +0.28% GOLD $4,077 +0.07% BTC $81,598 +0.98% VIX 16.87 −3.71% latest tape · as of 20:04 UTC
The Screen · Industrials · Electrical Equipment & Parts

Preformed Line Products Company logoPreformed Line Products Company

PLPC · Nasdaq · USD · Market cap $1.8B · 3,734 employees

Preformed Line Products Company designs and manufactures products and systems employed in the construction and maintenance of overhead, ground-mounted, and underground networks in the United States, the Americas, Europe,…

PASS · Titan Ethical · score 70.0
349.42 USD

Price as of 27 Oct 2026Daily close, not a live quote

Screened 2026-10-27 · the tape above runs as of 20:04 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price349.42 USD at the 27 Oct 2026 close
  • Ethical screenPasses, score 70.0 out of 100
  • Last reviewed27 Oct 2026 (1 days ago)

A summary of the dated readings below, not a live quote and not advice.

PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
480.00480.00480.00

What this means: price 349.42 against the desk's fair-value range, base estimate 480.00, over the last year.

Current read
Distribution ?
Screened · screened 2026-10-27
  • Trend Distribution
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical passes the values gate
Price349.42 USD
Fair value480.00
Ethical score70.0/100
Our investment reviews on this name
2026-10-24Read Distribution361.46-3.3% to today ✓Markdown gives way to Distribution
2026-10-18Read Markdown369.68-5.5% to today ✓Distribution gives way to Markdown after a 12% slide in 7 days
2026-10-11Read Distribution421.52-17.1% to today ✓Accumulation gives way to Distribution
2026-10-02Read Accumulation421.59-17.1% to today Distribution gives way to Accumulation

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its distribution label.

Preformed Line Products Company holds its Distribution at $349.42. The statistical read favours the sellers, held for 23 days.

As held on the ledger · 2026-10-27
PhaseDistribution · caution
Quantitative stateThe statistical read favours the sellers, held for 23 days
Price at the screen$349.42
Valuation40.75 trailing · N/A forward price to earnings
Values screenPASS · score 70.0
Beta0.90
The Workings

Five Screens, Shown in Full

Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 7.21% Below 33% Interest-bearing debt is just 7.2% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 30.07% Below 49% Money owed to the company is 30.1% of assets, under the 49% limit. Pass
Revenue purity 0.35% Below 5% Only 0.3% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Clears, in Plain English

Preformed Line Products clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 7%, inside the ~33% line, and almost none of its income is interest, so it passes.

Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when PLPC's ethical verdict changes

Today PLPC passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

480.00Conservative480.00Base case480.00Growth case 349.42Price

Fair value range in USD, drawn from the 2026-10-27 screen. The gold marker is the market price at the same screen. A 32.8% margin of safety to the base estimate.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections
$512$278$44TODAY5y agoPROJECTIONConservative$480.00 +36%Street avg$480.00 +36%Our fair value$480.00 +36%Street high$480.00 +36%

Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-27 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Grid hardware firm shows growth but slim profits

Every time a storm hits or a new solar array goes live, crews need tough clamps and connectors to keep the wires up. Preformed Line Products makes those essential bits for power networks from the Americas to Asia Pacific. Demand looks solid right now.

Revenue is rising 19 percent, the shares sit 14 percent below our fair value mark and the ethical screen is clear. Yet profit margins of 5 percent and an 8 percent return on equity do not build much excitement, and the lack of a known moat explains why we pass.

Utility budgets can swing hard with interest rates and raw material costs, while overseas sales add currency noise. Thin returns on capital could stay that way if bigger rivals crowd in. Analysis, not advice.

The fundamentals · plain-English read
Trailing P/E40.8xexpensive: the price assumes strong growth ahead
EPS, trailing8.87
Revenue growth+25.4%strong top-line growth
Profit margin5.8%thin but positive margins
Return on equity9.0%a modest return on shareholder capital
FCF yield1.10%
Dividend yield22.00%
Debt to equity0.11minimal debt: a conservative balance sheet
Current ratio2.99comfortably covers its short-term bills
Beta0.90steadier than the market
Short interest, float0.07%
52-week range184.02 - 504.69
Market cap$1.8B
Employees3,734

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

PLPC trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-10-28 Distribution $361.46 +0.0% Entry 16

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 132%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $372. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-27 Distribution $361.46 +0.0% Entry 15

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 132%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $372. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-26 Distribution $361.46 +0.0% Entry 14

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 132%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $372. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-25 Distribution $361.46 +0.0% Entry 13

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 132%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $372. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-24 Distribution · changed $361.46 +0.0% Entry 12

The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 132%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $372. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-23 Markdown $361.46 +0.0% Entry 11

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 132%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $372. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-22 Markdown $361.46 -2.2% Entry 10

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 132%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $372. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-21 Markdown $369.68 +0.0% Entry 9

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 132%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $372. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-18 Markdown · changed $369.68 -12.3% Entry 8

The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 12.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 53% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 132%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $372.

2026-10-11 Distribution · changed $421.52 0.0% Entry 7

The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 53% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 132%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $372.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on PLPC

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in PLPC's Space

Screened names in the same industry · explore each on its own page.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $356.98 -1.1% · $989 -1.1%
2 months $311.97 +13.2% · $1,132 +13.2%
3 months $260.64 +35.5% $0.21 $1,356 +35.6%
6 months $231.09 +52.8% $0.42 $1,530 +53.0%
1 year $152.36 +131.8% $0.82 $2,323 +132.3%
2 years $126.92 +178.2% $1.62 $2,795 +179.5%
3 years $162.16 +117.8% $2.42 $2,192 +119.2%
5 years $76.43 +362.0% $4.02 $4,672 +367.2%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever PLPC does next, these words stay.

Preformed Line Products Company · PLPC · Distribution · $349.42
Recorded 2026-10-27 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.